STAT Plus: AbbVie uses dozens of patents to ward off competition for a pricey cancer medicine
RUBY WALLAU FOR STAT
"There’s probably more innovation in the legal drafting of the patents than the drug research," said Tahir Amin of I-MAK,which studies drug patents.
.png)
No hay comentarios:
Publicar un comentario